AquaBounty Technologies, Inc. (NASDAQ:AQB) Sees Large Decline in Short Interest

AquaBounty Technologies, Inc. (NASDAQ:AQB) was the target of a significant drop in short interest in January. As of January 15th, there was short interest totalling 291,500 shares, a drop of 31.1% from the December 31st total of 423,300 shares. Currently, 7.7% of the company’s stock are short sold. Based on an average daily volume of 465,900 shares, the short-interest ratio is presently 0.6 days.

Institutional Investors Weigh In On AquaBounty Technologies

A hedge fund recently raised its stake in AquaBounty Technologies stock. Epiq Partners LLC boosted its position in shares of AquaBounty Technologies, Inc. (NASDAQ:AQB) by 423.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 89,000 shares of the company’s stock after acquiring an additional 72,000 shares during the quarter. Epiq Partners LLC owned 2.30% of AquaBounty Technologies worth $56,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 8.92% of the company’s stock.

AquaBounty Technologies Stock Up 3.8 %

AQB stock traded up $0.03 during midday trading on Friday, hitting $0.72. The company’s stock had a trading volume of 89,344 shares, compared to its average volume of 299,068. The company’s fifty day moving average price is $0.78 and its 200 day moving average price is $1.06. The company has a debt-to-equity ratio of 0.05, a current ratio of 3.02 and a quick ratio of 2.98. AquaBounty Technologies has a twelve month low of $0.47 and a twelve month high of $2.79. The stock has a market capitalization of $2.78 million, a P/E ratio of -0.04 and a beta of 1.17.

AquaBounty Technologies (NASDAQ:AQB) last released its earnings results on Tuesday, November 5th. The company reported ($0.88) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.88). AquaBounty Technologies had a negative return on equity of 18.20% and a negative net margin of 5,842.69%. The business had revenue of $0.05 million for the quarter, compared to analyst estimates of $0.10 million. During the same quarter in the prior year, the company posted ($1.60) earnings per share.

AquaBounty Technologies Company Profile

AquaBounty Technologies, Inc, a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.